Tvardi Therapeutics, Inc. S-8 Filing

From the Filing

EDGAR Filing Documents for 0001104659-26-038133 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form S-8 - Securities to be offered to employees in employee benefit plans: SEC Accession No. 0001104659-26-038133 Filing Date 2026-04-01 Accepted 2026-04-01 06:10:39 Documents 14 Effectiveness Date 2026-04-01 Interactive Data Document Format Files Seq Description Document Type Size 1 FORM S-8 tm2610047d3_s8.htm S-8 52194 2 EXHIBIT 5.1 tm2610047d3_ex5-1.htm EX-5.1 9563 3 EXHIBIT 23.1 tm2610047d3_ex23-1.htm EX-23.1 1912 4 EX-FILING FEES tm2610047d3_ex-filingfees.htm iXBRL EX-FILING FEES 22337 5 GRAPHIC tm2610047d3_ex5-1img001.jpg GRAPHIC 10321 Complete submission text file 0001104659-26-038133.txt 233464 Data Files Seq Description Document Type Size 17 EXTRACTED XBRL INSTANCE DOCUMENT tm2610047d3_ex-filingfees_htm.xml XML 9402 Mailing Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 Business Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 (713) 489-8654 Tvardi Therapeutics, Inc. (Filer) CIK : 0001346830 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: S-8 | Act: 33 | File No.: 333-294813 | Film No.: 26824552 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)